Article Details
Retrieved on: 2021-04-12 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
He also pointed out that “many of FDA's CMC regulators started in the monoclonal antibody industry and are cognizant of pitfalls related to rapid ...
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here